GRAIL’s Galleri Test Shows High Accuracy to Detect Aggressive Prostate Cancers
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Prostate |
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Prostate |
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Unknown Origin & Other Cancer Types |
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Chris Wolski | Aug 6, 2024 | Prostate |
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read More